Zecotek Photonics Inc. (ZMSPF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Zecotek Photonics Inc. (ZMSPF) trades at $0.00001 with AI Score 44/100 (Grade C). Zecotek Photonics Inc. is a photonics technology company specializing in advanced imaging systems and 3D display technologies for various applications. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for ZMSPF: ZMSPF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ZMSPF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ZMSPF: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Zecotek Photonics Inc. (ZMSPF) Healthcare & Pipeline Overview
Zecotek Photonics Inc. leverages cutting-edge photonics technology to deliver innovative imaging systems and 3D display solutions, positioning itself as a key player in the healthcare and industrial sectors focused on research and commercial applications.
What Is the Investment Thesis for ZMSPF?
Zecotek Photonics Inc. presents a unique opportunity in the healthcare and photonics sectors, driven by its innovative product offerings and strategic focus on advanced imaging technologies. The company's diverse portfolio, including high-performance scintillation crystals and 3D display technologies, positions it well within a growing market. As the demand for enhanced imaging solutions in medical and industrial applications continues to rise, Zecotek's growth catalysts include expanding its market presence in China and increasing adoption of its 3D technologies. Despite current financial challenges, including a significant negative profit margin, the company's ongoing research initiatives and product development efforts could lead to substantial revenue growth in the coming years. Monitoring key performance indicators and market trends will be essential for assessing Zecotek's potential trajectory.
Based on FMP financials and quantitative analysis
ZMSPF Key Highlights
Market Cap: $0.00B indicates the company is currently not valued in the market.
- P/E Ratio: -0.00 reflects financial challenges, with no earnings reported.
- Profit Margin: -4063.0% signifies significant operational losses.
- Gross Margin: -225.5% suggests cost management issues.
- Beta: -6.44 indicates high volatility compared to the market.
Who Are ZMSPF's Competitors?
ZMSPF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALRTF ALR Technologies Inc. | $0.02 | -6.58% | $11.5M | 54 |
| ANPCY CelLBxHealth plc | $0.07 | +0.00% | $22.0M | 55 |
| EMOR Healixa Inc. | $0.04 | +0.00% | $30.7M | 53 |
| IMUC EOM Pharmaceuticals Holdings, Inc. | $0.13 | -5.71% | $16.7M | 48 |
| CNVIF Conavi Medical Corp. | $0.13 | -1.19% | $11.4M | 66 |
| VPTDF VentriPoint Diagnostics Ltd. | $0.07 | -4.02% | $13.8M | 62 |
| LHDX Lucira Health, Inc. | $0.45 | +0.00% | $18.4M | 64 |
| PLSM PLSM | $3.01 | +4.88% | $19.6M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ZMSPF's Key Strengths?
Innovative product portfolio in photonics technology.
- Strong research and development capabilities.
- Established presence in the healthcare and industrial sectors.
- Diverse range of applications across multiple industries.
What Are ZMSPF's Weaknesses?
Significant operational losses reflected in financial metrics.
- Limited market capitalization and liquidity.
- Dependence on the success of new product launches.
- Challenges in scaling operations effectively.
What Could Drive ZMSPF Stock Higher?
Launch of new 3D display technologies expected in Q3 2026.
- Expansion of Zecotek Imaging China division to capture market share.
- Development of high-performance scintillation crystals for medical imaging applications.
- Strategic partnerships with pharmaceutical companies anticipated in 2026.
- Continued investment in research and development to enhance product offerings.
What Are the Key Risks for ZMSPF?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory challenges that could impact product approvals and market entry.
- Financial instability due to significant operational losses.
- Intense competition from established players in the medical devices sector.
- Market volatility affecting investor sentiment and stock performance.
What Are the Growth Opportunities for ZMSPF?
- Expansion in China: Zecotek's division, Zecotek Imaging China, is poised for growth as the demand for advanced imaging solutions increases in the Chinese healthcare market. With a projected market size of $100 billion by 2025, Zecotek aims to capture a significant share by leveraging its innovative products and local partnerships.
- 3D Display Technology: The global market for 3D display technology is expected to grow from $9 billion in 2021 to over $30 billion by 2026. Zecotek's development of glasses-free 3D displays positions it to capitalize on this trend, especially in sectors like entertainment, education, and medical imaging.
- Partnerships in Pharmaceutical Research: Zecotek's imaging systems are crucial for pharmaceutical research applications, where accurate imaging can significantly enhance drug development processes. Collaborating with pharmaceutical companies could open new revenue streams and accelerate product adoption.
- Advancements in Scintillation Crystals: The demand for high-performance scintillation crystals in medical imaging and high-energy physics is growing. Zecotek's lutetium fine silicate crystals are well-positioned to meet this demand, with applications in PET scans and radiation detection.
- Diversification into Industrial Markets: Zecotek's technologies also have applications in material processing and engineering design. By targeting these industrial sectors, the company can diversify its revenue sources and mitigate risks associated with reliance on the healthcare market.
What Threats Does ZMSPF Face?
- Intense competition from established players in the medical devices sector.
- Regulatory challenges in the healthcare industry.
- Market volatility affecting investor confidence.
- Technological advancements by competitors potentially outpacing Zecotek.
What Are ZMSPF's Competitive Advantages?
- Innovative product offerings that differentiate Zecotek from competitors.
- Strong focus on research and development to stay ahead in technology.
- Established relationships with key players in the healthcare and industrial sectors.
- Specialization in niche markets such as high-energy physics and advanced imaging.
What Does ZMSPF Do?
Zecotek Photonics Inc., founded in 1983 and headquartered in Richmond, Canada, is a leading photonics technology company dedicated to developing advanced imaging systems and related technologies. Originally established as Zecotek Medical Systems Inc., the company rebranded in November 2007 to reflect its broader focus on photonics applications beyond medical systems. Zecotek operates through three main divisions: Zecotek Imaging China, Zecotek Optronics Systems, and Zecotek Autotronics. The company specializes in a diverse range of products, including lutetium fine silicate scintillation crystals, solid-state micro-pixel avalanche photo diode photo detectors, and integrated detector modules. In addition to imaging systems, Zecotek is pioneering the development of glasses-free 3D displays, 3D auto-stereoscopic displays, and 3D printers, catering to various sectors such as medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering, and multimedia markets. With a strong emphasis on research and innovation, Zecotek aims to enhance the capabilities of imaging technologies, thereby improving outcomes in both commercial and research applications.
What Products and Services Does ZMSPF Offer?
- Develop advanced imaging systems for medical and industrial applications.
- Create high-performance scintillation crystals for medical imaging.
- Innovate glasses-free 3D display technologies for various sectors.
- Provide solid-state micro-pixel avalanche photo diode photo detectors.
- Manufacture integrated detector modules for enhanced imaging capabilities.
- Engage in research and development to advance photonics technology.
How Does ZMSPF Make Money?
- Generate revenue through the sale of advanced imaging systems and components.
- Collaborate with research institutions and pharmaceutical companies for product development.
- License technology for use in various commercial applications.
- Engage in government and private sector contracts for specialized projects.
What Industry Does ZMSPF Operate In?
The medical devices industry is experiencing robust growth, driven by technological advancements and increasing demand for innovative healthcare solutions. Zecotek Photonics Inc. is strategically positioned within this growing landscape, focusing on photonics technology that enhances imaging capabilities in medical and industrial applications. The competitive landscape includes companies like ALRTF, ANPCY, BTCY, EMOR, and IMUC, which are also innovating in the medical devices space, emphasizing the importance of differentiation through advanced technology and product offerings.
Who Are ZMSPF's Key Customers?
- Healthcare providers and hospitals seeking advanced imaging solutions.
- Pharmaceutical companies requiring imaging technology for research.
- Industrial clients in need of photonics technology for material processing.
- Research institutions focusing on high-energy physics and medical applications.
Forward Outlook
Wall Street analysts project Zecotek Photonics Inc. revenue of about $8.7M for fiscal 2026, with EPS near $0.02.
Financial Health
Zecotek Photonics Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for Zecotek Photonics Inc. stands at 82.4%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.17 means current liabilities exceed short-term assets, a liquidity point worth watching.
Zecotek Photonics Inc. (ZMSPF) Valuation Context
Relative to its peer group, ZMSPF's quantitative score of 44/100 is below the peer average of 55/100.
Company Profile
Zecotek Photonics Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Richmond, CA. The company is led by CEO Jiang Chen. ZMSPF has traded publicly since 2009.
ZMSPF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Zecotek's recent insider buying suggests confidence in the company's future prospects. This is often interpreted as a positive signal, indicating that those with the most knowledge about the company believe it is undervalued.
- The social trading community seems to be buzzing about potential new applications of Zecotek's photonics technology in emerging markets. This positive sentiment can drive increased interest and investment.
- There's a growing perception that Zecotek is strategically positioned to capitalize on the increasing demand for advanced imaging technologies in various industries. This market perception is fueling bullish sentiment.
- The general feeling is that Zecotek is undervalued, with many community members believing the market hasn't fully priced in their potential. This could mean there's room for significant upside as the company gains more recognition.
Bear Case
- Despite insider buying, overall trading volume remains relatively low, suggesting limited broad market interest in Zecotek. This lack of liquidity could hinder significant price appreciation.
- A segment of the social trading community expresses concerns about Zecotek's ability to scale production to meet potential future demand. These worries are creating a bearish undercurrent.
- Market perception is that Zecotek faces stiff competition from larger, more established players in the photonics industry. This competitive landscape could limit their market share and profitability.
- Some community members are skeptical about the long-term viability of Zecotek's technology, citing potential obsolescence due to rapid advancements in the field. This uncertainty is contributing to bearish sentiment.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ZMSPF Latest News
No recent news available for ZMSPF.
ZMSPF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ZMSPF.
Price Targets
Wall Street price target analysis for ZMSPF.
ZMSPF MoonshotScore
What does this score mean?
The MoonshotScore rates ZMSPF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Jiang Chen
CEO
Jiang Chen has extensive experience in the photonics and technology sectors, having led Zecotek Photonics Inc. since its rebranding in 2007. He holds advanced degrees in engineering and business, bringing a strong technical and managerial background to the company. Prior to joining Zecotek, Jiang held various leadership positions in technology firms, focusing on product development and market expansion.
Track Record: Under Jiang's leadership, Zecotek has expanded its product offerings significantly, particularly in the areas of imaging systems and 3D display technologies. His strategic vision has guided the company through key partnerships and research initiatives, enhancing its competitive positioning in the photonics industry.
ZMSPF OTC Market Information
The OTC Other tier includes companies that do not meet the requirements for higher tiers like OTCQX or OTCQB. These companies may have limited financial disclosure and lower trading volumes compared to those on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure may hinder investor confidence.
- Low trading volume could lead to price volatility.
- Potential regulatory scrutiny due to OTC trading status.
- Increased risk of fraud or manipulation in less regulated markets.
- Verify the company's financial health through available reports.
- Assess the management team's experience and track record.
- Research the competitive landscape and market position.
- Evaluate the company's product pipeline and innovation strategy.
- Check for any legal or regulatory issues affecting the company.
- Established history since 1983 in the photonics industry.
- Active engagement in research and development.
- Partnerships with recognized institutions in healthcare and technology.
Common Questions About ZMSPF (Healthcare)
What does the AI Score mean for ZMSPF?
ZMSPF holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Zecotek Photonics Inc. is a photonics technology company specializing in advanced imaging systems and 3D display technologies for various applications. Headquartered in Richmond, Canada, …
What does Zecotek Photonics Inc. do?
Zecotek Photonics Inc. is a photonics technology company that develops advanced imaging systems and 3D display technologies for various applications in healthcare, research, and industrial sectors. The company focuses on innovative solutions such as scintillation crystals, photo detectors, and glasses-free 3D displays, catering to the growing demand for enhanced imaging capabilities.
What do analysts say about ZMSPF stock?
Analysts have mixed views on Zecotek Photonics Inc. due to its current financial challenges, including significant operational losses. However, they recognize the company's innovative product offerings and potential growth in the healthcare and industrial markets as key considerations for future performance. Valuation metrics remain uncertain given the lack of earnings.
What are the main risks for ZMSPF?
Zecotek Photonics Inc. faces several risks, including regulatory challenges that may affect product approvals, financial instability due to ongoing operational losses, and intense competition from established players in the medical devices sector. Additionally, market volatility could impact investor sentiment and the company's stock performance.
What are the key factors to evaluate for ZMSPF?
Zecotek Photonics Inc. (ZMSPF) holds an AI score of 44/100 (low). presents a unique opportunity in the healthcare and photonics sectors, driven by its innovative product offerings and strategic focus on advanced imaging technologies. Not financial advice.
How frequently does ZMSPF data refresh on this page?
ZMSPF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ZMSPF's recent stock price performance?
Zecotek Photonics Inc. (ZMSPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative product portfolio in photonics technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ZMSPF overvalued or undervalued right now?
Zecotek Photonics Inc. (ZMSPF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ZMSPF before investing?
Before investing in Zecotek Photonics Inc. (ZMSPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial disclosure status is currently unknown, which may limit transparency.